维洛克萨延长释放:成人注意力缺陷/多动障碍的综述
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. demail@springer.com.
维洛克萨ER (延长释放) 是一种新的口服囊,有效治疗注意力缺陷/多动症障碍 (ADHD) 的成年人. 这种上腺素再吸收抑制剂证明了持续的症状减少和改善的执行功能,具有耐受良好的安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 注意缺陷/多动障碍 (ADHD) 是一种流行的神经发育障碍.
- 成年ADHD的药理疗法正在不断发展.
- 维洛克萨ER (Qelbree®) 是一种新型的上腺素再吸收抑制剂和血清素受体调节剂.
研究的目的:
- 审查维洛克萨ER在治疗成人多动症时的疗效和安全性.
- 提供维洛克萨ER药理性质的概述.
- 评估维洛克萨ER在成人多动症治疗领域的作用.
主要方法:
- 一个随机,双盲,安慰剂控制的,为期6周的第三阶段试验的综述.
- 对维洛克萨ER对ADHD症状,严重程度和执行功能的影响的分析.
- 对成年患者的安全性和耐受性数据的评估.
主要成果:
- 维洛克萨ER显著降低了成年人的ADHD症状和严重程度.
- 观察到执行功能的改善.
- 治疗效益持续超过24个月.
- 维洛克萨ER一般耐受良好,失眠和头痛是常见的不良事件.
- 没有发现临床上显著的心血管或肝脏不良反应.
结论:
- 维洛克萨ER是成年ADHD患者的有效和耐受性良好的治疗选择.
- 它提供持续的症状控制和改善的执行功能.
- 维洛克萨ER代表了成年ADHD可用的治疗策略的宝贵补充.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
相关概念视频
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
